Radiation Oncology/Therapy: Page 51

Breast MRI useful in detecting early interval cancers

By Amerigo Allegretto

Supplemental screening with MRI is a good tool for detecting interval cancers in women with a personal history of breast cancer, with several patient characteristics linked to likelihood of cancer, according to research published June 8 in Radiology.

June 8, 2021

Novartis touts prostate cancer study results at ASCO 2021

By AuntMinnie.com staff writers

Novartis highlighted results presented at the virtual American Society of Clinical Oncology meeting that suggest lutetium-177 prostate-specific membrane antigen-617 is safe and effective for patients with PSMA-positive metastatic prostate cancer.

June 7, 2021

Philips, Elekta dive deeper into cancer care collaboration

By AuntMinnie.com staff writers

Philips Healthcare parent company Royal Philips and radiation oncology vendor Elekta have signed agreements to deepen their existing collaborative efforts on personalized cancer care.

June 6, 2021

Will physicians trust radiation therapy planned by AI?

By Erik L. Ridley

Radiation oncologists may favor radiation therapy plans produced by a machine-learning algorithm in simulations, but trusting in the plans for clinical use may be a different matter, according to research published online June 3 in Nature Medicine.

June 3, 2021

ImaginAb lands $13M in growth funding

By AuntMinnie.com staff writers

Radiopharmaceutical developer ImaginAb has raised almost $13 million in funding to support the company's growth and further development of its CD8 Immuno-PET agent.

June 2, 2021

Fusion Pharmaceuticals to build radiopharma plant in Canada

By AuntMinnie.com staff writers

McMaster University spin-off company Fusion Pharmaceuticals announced it has entered a 15-year lease agreement with the school for a new manufacturing facility for therapeutic pharmaceuticals near its campus in Hamilton, Ontario.

June 2, 2021

GenesisCare among early providers to offer Pylarify

By AuntMinnie.com staff writers

Lantheus Medical Imaging has announced that oncology provider GenesisCare will be the first to administer commercially available doses of its Pylarify PET radiopharmaceutical, which was approved last month.

June 2, 2021

RaySearch releases update of RayStation software

By AuntMinnie.com staff writers

Radiation therapy software developer RaySearch Laboratories has released 11A, a new version of its RayStation treatment planning software.

June 1, 2021

Elekta reaches Elekta Unity milestone

By AuntMinnie.com staff writers

Radiation oncology vendor Elekta has installed its 100th Unity MR-Linac system at St. George's Hospital in Christchurch, New Zealand.

May 31, 2021

Varian nets FDA breakthrough nod for radioablation unit

By AuntMinnie.com staff writers

Radiation oncology vendor Varian Medical Systems has garnered a breakthrough device designation from the U.S. Food and Drug Administration (FDA) for its cardiac radioablation system.

May 27, 2021

Blue Earth touts Axumin results in Lancet

By AuntMinnie.com staff writers

Bracco molecular imaging subsidiary Blue Earth Diagnostics is highlighting results of a study published in Lancet showing that postprostatectomy radiation therapy guided by the company's PET radiotracer Axumin (fluciclovine F-18) helped increase biochemical event-free survival rates in men with recurrent prostate cancer.

May 26, 2021

NorthStar partners with Clarity, Monopar

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes and radiopharmaceutical firm Clarity Pharmaceuticals are joining forces on the supply of the therapeutic radioisotope copper-67. NorthStar is also partnering with biopharmaceutical firm Monopar Therapeutics on a patent.

May 24, 2021

Previous Page

Page 51 of 465

Next Page